Covid-19: WHO recommends baricitinib and sotrovimab to treat patients
Zosia Kmietowicz
Abstract
Covid-19: WHO recommends baricitinib and sotrovimab to treat patients Zosia KmietowiczThe Janus kinase (JAK) inhibitor baricitinib, which is also used to treat rheumatoid arthritis, is strongly recommended for patients with severe or critical covid-19 in combination with corticosteroids, an expert group from the World Health Organization has written in The BMJ.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusMedicineCoronavirus InfectionsComputer scienceData scienceVirologyOutbreakInternal medicineDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsPhagocytosis and Immune Regulation